These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2235345)

  • 1. [Clinical efficacy of Z-100 for the treatment of leukopenia caused by radiotherapy--a multi-center double-blind comparative study with inosine].
    Hashimoto S; Ohkawa T; Takekawa Y; Horiuchi J; Mori T; Amino S; Morita K; Tanaka Y; Mochizuki Y; Yanagisawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):977-92. PubMed ID: 2235345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of Z-100 for the treatment of leukopenia caused by radiotherapy--a multi-center double-blind comparative study with L-cysteine].
    Hashimoto S; Ohkawa T; Takekawa Y; Horiuchi J; Mori T; Amino S; Morita K; Tanaka Y; Mochizuki Y; Yanagisawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Aug; 50(8):993-1006. PubMed ID: 2235346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An early clinical study of Z-100 in leukopenia caused by radiotherapy].
    Hashimoto S; Yanagisawa T; Mochizuki S; Ohkawa T; Amino S; Horiuchi J; Kamata R; Mori T; Tanaka Y; Takekawa Y
    Rinsho Hoshasen; 1990 Jun; 35(6):709-14. PubMed ID: 2388408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better.
    Noda K; Ohashi Y; Sugimori H; Ozaki M; Niibe H; Ogita S; Kohno I; Hasegawa K; Kikuchi Y; Takegawa Y; Fujii S; Tanaka K; Ochiai K; Kita M; Fujiwara K
    Gynecol Oncol; 2006 Jun; 101(3):455-63. PubMed ID: 16360199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Restorative effect of muroctasin; MDP-Lys (L18) [DJ-7041] on leukopenia in urogenital cancer patients treated with chemotherapy].
    Oishi K; Takeuchi H; Yoshida O; Nakagawa K; Fukuyama T; Okamoto K; Kihara Y; Okuno H; Shirahase T; Tomoyoshi T
    Hinyokika Kiyo; 1989 Mar; 35(3):527-36. PubMed ID: 2660519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leukopenia and lymphopenia during the radiation therapy and their recovery by anti-leukopenia drugs (author's transl)].
    Makidono R; Makidono A; Matsuura K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1977 Dec; 37(12):1153-67. PubMed ID: 609534
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience in the use of Selfer for leukopenia].
    Tai Y
    Horumon To Rinsho; 1972 Mar; 20(3):243-6. PubMed ID: 5065703
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restorative activity of muroctasin on leukopenia associated with anticancer treatment.
    Tsubura E; Nomura T; Niitani H; Osamura S; Okawa T; Tanaka M; Ota K; Nishikawa H; Masaoka T; Fukuoka M
    Arzneimittelforschung; 1988 Jul; 38(7A):1070-4. PubMed ID: 3190800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
    Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
    Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapy.
    Noda K; Ohashi Y; Okada H; Ogita S; Ozaki M; Kikuchi Y; Takegawa Y; Niibe H; Fujii S; Horiuchi J; Morita K; Hashimoto S; Fujiwara K
    Jpn J Clin Oncol; 2006 Sep; 36(9):570-7. PubMed ID: 16926224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restorative effect of romurtide for thrombocytopenia associated with intensive anticancer drug treatment and/or irradiation in patients with gastrointestinal cancer.
    Yano K; Matsuoka H; Seo Y; Kounoe S; Saito T; Tomoda H
    Anticancer Res; 1995; 15(6B):2883-7. PubMed ID: 8669883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
    Schwid SR; Panitch HS
    Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of SN-307 (ondansetron), given intravenously in the treatment of nausea and vomiting caused by anticancer drugs including cisplatin--a placebo-controlled, double-blind comparative study].
    Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2071-84. PubMed ID: 1417015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of filgrastim, granulocyte colony stimulating factor (G-CSF), in radiotherapy to reduce drop-outs because of radiogenic leukopenia].
    Gava A; Bertossi L; Ferrarese F; Coghetto F; Marazzato G; Andrulli AD; Zorat PL
    Radiol Med; 1998 Mar; 95(3):232-6. PubMed ID: 9638171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cepharanthin on radiotherapy induced leukopenia].
    Ohta T; Morita K
    Rinsho Hoshasen; 1990 Apr; 35(4):471-4. PubMed ID: 2192184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study on intravenous drip infusion of dibekacin once daily and twice daily in treatment of complicated urinary tract infections].
    Kishi H; Kaneco H; Tominaga T; Niijima T; Nishimura Y; Saito I; Ishii Y; Nito H; Yuge J; Asano M
    Hinyokika Kiyo; 1984 Jan; 30(1):103-20. PubMed ID: 6375317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.